Notice of Investor Presentation
SkinBioTherapeutics plc has announced a presentation for shareholders scheduled for 9am BST on Monday, June 29, 2026, which will be led by the Acting Chair and Interim CEO. This presentation is accessible to all current and prospective shareholders, with the opportunity to submit questions in advance via the Investor Meet Company dashboard until 9am BST on June 28, 2026, or during the live event. Investors can register for free on the Investor Meet Company platform to receive an invitation.
Select text to share a quote on X · sign in to keep highlights & notes in your SBTX notes
23 June 2026 - SkinBioTherapeutics plc, (AIM: SBTX), the life sciences business focused on skin health, will be presenting to shareholders at 9am BST on Monday 29 June 2026. The presentation will be led by Alyson Levett, Acting Chair and Rachel Parsonage, Interim CEO.
The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via the Investor Meet Company dashboard up until 28 Jun 2026, 9am BST, or at any time during the live presentation.
Investors can sign up to Investor Meet Company for free and add to meet SkinBioTherapeutics via the link HERE. Investors who already follow SkinBioTherapeutics on the Investor Meet Company platform will automatically be invited.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.